Pursuing Disease Causation to Foster the Creation of Targeted Microbiome Based Therapeutics, Biomarkers & Diagnostics

Welcome to the 5th Microbiome Movement - Drug Development Summit 2020

The Microbiome Movement – Drug Development Summit continues to be the industry-leading forum to help forward thinking researchers from the pharmaceutical, biotech and academic community pursue the causal role of the human microbiome in disease, to create a new generation of targeted treatments that demonstrate consistent clinical outcomes and predictable MoAs.

If you are, or would like to be, a player in the microbiome arena, this is the conference you should attend to not only hear the latest pre-clinical and clinical development from organizations developing microbiome-based therapeutics, biomarkers and diagnostics, but also to make long-lasting connections that will accelerate your microbiome developments forward, and help translate this promising science into a reality for patients.

Meet Our 60+ Expert Speaker Faculty Including

Barbara McGovern

MD, VP Medical Affairs

Seres Therapeutics

Bernat Olle

CEO

Vedanta Biosciences

Christophe Bonny

CSO

Enterome

Deepak Gopalakrishnan

Scientist - Microbiome Discovery

AstraZeneca

Jackie Papkoff

Chief Scientific Officer

Assembly Biosciences

Jessica Allegretti

MD, Director Clinical Trials

Brigham & Women’s Hospital

Ken Blount

CSO

Rebiotix

Libusha Kelly

Associate Professor

Albert Einstein College of Medicine

Lynn Bry

Director

Massachusetts Host Microbiome Center

Mark Smith

CEO

Finch Therapeutics

Paul Peter Tak

President & CEO

Kintai Therapeutics

Yogesh Mudaliar

Research Investigator Drug Product Development

Takeda Pharmaceuticals

Hear What Our Customers Say

"This is far and away the best of the microbiome therapeutics conferences I’ve attended. Always up to date, relevant topics, and speakers from a wide range of companies. The networking opportunities alone are fantastic”

Julius Goepp, CEO, Scaled Microbiomics

“The Microbiome Movement – Drug Development Summit is probably the most important meeting to attend for anyone involved in microbiome drug development

Julie Schwedock, CMC Associate Scientific Fellow, Takeda

Confirmed Partners for 2020 Include

Lead Partner:

Boston Analytical

Expertise Partners:

ArrantaBio-Logo
DNAgenotek_Logo_Spot
CosmosID

Other Confirmed Partners:

2778561487350159120
Biomodels-Logo-final
New-biose-industrie-002
BACTHERA_logo_RGB_black-002
main-logo
polardry_logo_wtag 110419
Luina-Bio-Header
renderimage
download
download
pQ1D9Bpr
HMT Logo
download
AltisLogo_CMYK_HighRes
2333

Other Events In The Series